Daily Bulletin

Men's Weekly

.

IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer

Highlights

  • IND approval received for SAR-Bombesin product, enabling a Phase II "SABRE" imaging trial to detect prostate cancer in up to 50 PSMA-negative participants in the US
  • Approximately 20% of prostate cancer patients with biochemical recurrence (BCR) are PSMA-PET negative and therefore unsuitable for the currently approved PSMA targeting...

Read more: IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer

Business News

Integrating Marketing Automation Workflows with Headless CMS: Creating a Unified Engine for Scalable Growth

Marketing automation is a necessary component of modern engagement with customers. Automated emails, triggered campaigns, lead nurturing and lifecycle messaging enable brands to scale their messagin...

Daily Bulletin - avatar Daily Bulletin

Why Split Corrugated Conduits Are Essential For Protecting Electrical And Solar Installations

Modern electrical systems require reliable protection for wiring and cables to ensure safety, durability, and long-term performance. In residential, commercial, and industrial environments, conduits a...

Daily Bulletin - avatar Daily Bulletin

Launching Global Product Campaigns with Decoupled Content Architecture

There's perhaps no more challenging project for an international enterprise to pursue than a global product launch campaign. At the same time, various regions, languages, compliance standards, digit...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business